Gene · 29843
Papers1,435
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,435
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SUMOylation is destined for regulatory T cell-related immune dysregulation. | Cell Death Discov | 2026 | 41633969 | PubTator, text mining | PubMed |
| Altitude hypoxia and hypoxemia: pathogenesis and management. | Signal Transduct Target Ther | 2026 | 41571626 | PubTator, text mining | PubMed |
| Retraction Note: SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis. | Nat Commun | 2026 | 41565686 | PubTator, text mining | PubMed |
| HBV X protein regulates cancer stemness and tumor invasiveness through SENP1 in hepatocellular carcinoma. | JHEP Rep | 2026 | 41438340 | PubTator, text mining | PubMed |
| Nuciferine inhibits pressure overload-induced cardiac remodeling by activating the SENP1-ACSL4-ferroptosis axis. | J Adv Res | 2026 | 40835001 | PubTator, text mining | PubMed |
| DENetwork unveils non-differentially expressed genes with functional relevance across conditions through information flow perturbation. | Nucleic Acids Res | 2025 | 41404797 | PubTator, text mining | PubMed |
| Naturally Derived SENP1 Inhibitors with Anticancer Activity. | Int J Mol Sci | 2025 | 41303693 | PubTator, text mining | PubMed |
| Death-associated protein kinase 1-dependent SENP1 degradation increases tau SUMOylation and leads to cognitive dysfunction in a mouse model for tauopathy. | Mol Neurodegener | 2025 | 41272902 | PubTator, text mining | PubMed |
| SUMOylation of ZEB1 Modulates PANoptosis in Burn-Induced Early Acute Kidney Injury. | J Cell Mol Med | 2025 | 41126444 | PubTator, text mining | PubMed |
| Monge's disease at 100 years: Revisiting the origins and endocrine mechanisms of chronic mountain sickness. | Sci Prog | 2025 | 41118472 | PubTator, text mining | PubMed |
| High expression of SENP1 correlates with poor prognosis and immune evasion in gastric cancer. | Int Immunopharmacol | 2025 | 41092770 | PubTator, text mining | PubMed |
| SENP1 drives glycolysis and cisplatin resistance in gastric cancer via desumoylating ENO1. | J Exp Clin Cancer Res | 2025 | 41063235 | PubTator, text mining | PubMed |
| Sentrin/SUMO-specific protease 1 contributes to drug resistance in melanoma by mediating the deSUMOylation of Yes-associated protein. | Postepy Dermatol Alergol | 2025 | 41001144 | PubTator, text mining | PubMed |
| SUMO conjugation to promoter-proximal sequence elements-associated proteins impacts on snRNA transcription. | Proc Natl Acad Sci U S A | 2025 | 40956881 | PubTator, text mining | PubMed |
| Phosphoprotein Profile of Ameloblastoma. | Asian Pac J Cancer Prev | 2025 | 40849725 | PubTator, text mining | PubMed |
| Targeting MondoA-TXNIP restores antitumour immunity in lactic-acid-induced immunosuppressive microenvironment. | Nat Metab | 2025 | 40846790 | PubTator, text mining | PubMed |
| Investigating Liquid-Liquid Phase Separation in Lung Adenocarcinoma to Improve Prognostic Accuracy and Treatment Efficacy. | J Cell Mol Med | 2025 | 40845073 | PubTator, text mining | PubMed |
| A molecular systems architecture of the mesenchymal stromal cell microenvironment. | Stem Cells | 2025 | 40843515 | PubTator, text mining | PubMed |
| Mitochondrial Quality Control: Insights into Intracerebral Hemorrhage. | Cell Mol Neurobiol | 2025 | 40810912 | PubTator, text mining | PubMed |
| A Simple, Quick, and Scalable Route to Fluorogenic Ubiquitin and Ubiquitin-Like Protein Substrates for Assessing Activities of Deubiquitinases and Ubiquitin-Like Protein-Specific Proteases. | ACS Chem Biol | 2025 | 40797270 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/29843/papers?page=2